Harpoon Therapeutics, Inc. - stock earnings
HARP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | 4.4 million USD |
| 2023Q2 | 1.1 million USD | 20.2 million USD |
| 2023Q1 | -12.0 million USD | 8.6 million USD |
| 2022Q4 | -18.1 million USD | 4.1 million USD |
| 2022Q3 | -11.4 million USD | 13.6 million USD |
| 2022Q2 | -17.3 million USD | 8.3 million USD |
| 2022Q1 | -20.3 million USD | 5.9 million USD |
| 2021Q4 | -21.6 million USD | 4.3 million USD |
| 2021Q3 | -16.7 million USD | 4.5 million USD |
| 2021Q2 | -16.8 million USD | 5.8 million USD |
| 2021Q1 | -61.7 million USD | 9.0 million USD |
| 2020Q4 | -11.4 million USD | 7.5 million USD |
| 2020Q3 | -13.3 million USD | 3.9 million USD |
| 2020Q2 | -12.7 million USD | 2.8 million USD |
| 2020Q1 | -12.6 million USD | 3.3 million USD |
| 2019Q4 | -14.3 million USD | 2.2 million USD |
| 2019Q3 | -15.9 million USD | 1.4 million USD |
| 2019Q2 | -11.8 million USD | 1.1 million USD |
| 2019Q1 | -13.6 million USD | 1.1 million USD |
| 2018Q4 | -9.7 million USD | 1.1 million USD |
| 2018Q3 | -6.8 million USD | 1.1 million USD |
| 2018Q2 | -6.0 million USD | 1.1 million USD |
| 2018Q1 | -4.9 million USD | 1.6 million USD |
| 2017Q4 | -4.9 million USD | 708000 USD |
HARP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.5 million USD | 37.3 million USD |
| 2022 | -67.1 million USD | 31.9 million USD |
| 2021 | -166.4 million USD | 23.7 million USD |
| 2020 | -46.4 million USD | 17.4 million USD |
| 2019 | -52.0 million USD | 5.8 million USD |
| 2018 | -27.4 million USD | 4.8 million USD |
| 2017 | -16.8 million USD | 708000 USD |
| 2016 | -11.4 million USD | ? USD |
HARP
Price: $23.01
52 week price:
Earnings Per Share: -1.53 USD
P/E Ratio: -14.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146491
Market Capitalization: 492.3 million